Punteggio di affidabilità 8/100
Dr Saad Rassam
👤 7 anni di esperienza
6,834+
Patients seen
7
Years in practice
5
Publications
2
Languages spoken
Informazioni
Dr Rassam Qualified in 1980 from the University of Baghdad. In 1986 he arrived to the UK on a scholarship for post-graduate training in haematology. He trained as a Registrar at the Royal Free Hospital, London and Edgware General Hospital and a Senior Registrar and University of London Lecturer at St Bartholomew's Hospital, University College Hospital and Hospital for Sick Children at Great Ormond Street. During his time as a senior registrar, he conducted research into immune reconstitution following stem cell transplantation in children with severe combined immune deficiency. He received his Membership of the Royal College of Physicians and the Royal College of Pathologists in 1989 and 1992 respectively and was elected as Fellow of both colleges in 1997 and 1999.
Dr Rassam has a special interest in the management of lymphoid malignancies and in research into the immune mechanisms and therapy of cancer. In 1997 he was awarded The Microscopical Society of Great Britain and Ireland Fellowship to study the technology and isolation of tumour infiltrating lymphocytes (the immune cells against cancer) at Harvard University in the USA. Following his return, he established a research laboratory at Queen Mary's Hospital to study the role of the immune system in lymphatic cancer. He later received grants to extend his research in non-Hodgkin lymphoma at the Rayne Institute in London with novel findings. He has presented his findings in National and International meetings.
Dr. Rassam was an active member of the low and high grade lymphoma subgroups of the National Cancer Research Institute (NCRI), the British Society of Haematology, the American Society of Haematology, The UK Waldenstroms Macroglobulinaemia Group and an author on the British Society of Haematology Guidelines in Waldenstrom's Macroglobulinaemia. He was an examiner and appointment advisory officer for the Royal College of Pathologists. He is the author of a number of National clinical trial proposals. He was also the chairman of the Hemato-Oncology Group in the Kent Cancer Network and responsible for updating the lymphoma and chronic lymphocytic leukaemia (CLL) pathways. He was the National Chief Investigator for the ASCEND study in CLL.
Diseases, Medical Tests and Treatments
Immunotherapy, Chemotherapy
General Haematology
Haematological oncology
Lymphoma: Hodgkin and non-Hodgkin
Myeloma and amyloid disease
Leukaemia
Myelodysplastic Syndromes
Dr Rassam has a special interest in the management of lymphoid malignancies and in research into the immune mechanisms and therapy of cancer. In 1997 he was awarded The Microscopical Society of Great Britain and Ireland Fellowship to study the technology and isolation of tumour infiltrating lymphocytes (the immune cells against cancer) at Harvard University in the USA. Following his return, he established a research laboratory at Queen Mary's Hospital to study the role of the immune system in lymphatic cancer. He later received grants to extend his research in non-Hodgkin lymphoma at the Rayne Institute in London with novel findings. He has presented his findings in National and International meetings.
Dr. Rassam was an active member of the low and high grade lymphoma subgroups of the National Cancer Research Institute (NCRI), the British Society of Haematology, the American Society of Haematology, The UK Waldenstroms Macroglobulinaemia Group and an author on the British Society of Haematology Guidelines in Waldenstrom's Macroglobulinaemia. He was an examiner and appointment advisory officer for the Royal College of Pathologists. He is the author of a number of National clinical trial proposals. He was also the chairman of the Hemato-Oncology Group in the Kent Cancer Network and responsible for updating the lymphoma and chronic lymphocytic leukaemia (CLL) pathways. He was the National Chief Investigator for the ASCEND study in CLL.
Diseases, Medical Tests and Treatments
Immunotherapy, Chemotherapy
General Haematology
Haematological oncology
Lymphoma: Hodgkin and non-Hodgkin
Myeloma and amyloid disease
Leukaemia
Myelodysplastic Syndromes
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Saad Rassam
Istruzione e formazione
-
2009–2015 MD · Medicine and Surgery
-
2015–2019 Residency · Ematologia
-
2019–2020 Fellowship · Subspecialty training
Carriera e incarichi
-
2019-09–2020-08 Junior consultant
Licenze e assicurazione
Licenze mediche
GB — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Ematologia
Assicurazione responsabilità professionale:
Generali Healthcare · 1,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 1,285 |
| Annual physical exam | 99395 | 2,419 |
| Vaccination administration | 90471 | 2,123 |
| Minor procedure (skin) | 17110 | 1,620 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 450.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 8 · i10: 8
-
European registry analysis of Ematologia outcomes
DOI: 10.9900/euroclin.2025.0 · PMID: 35425709 · citato da 101
-
Outcomes of Ematologia in adults — a multi-centre cohort
DOI: 10.8427/euroclin.2024.1 · PMID: 34264203 · citato da 111
-
European registry analysis of Ematologia outcomes
DOI: 10.7055/euroclin.2023.2 · PMID: 39634883 · citato da 129
Conferenze su invito
- Practical updates in Ematologia European Annual Congress (Ematologia) · Vienna · 2024 · invited
- Single-centre experience in Ematologia National Society Meeting · London · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Ematologia — London · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2020
- national college of family doctors — Member · Dal 2020
- European Union of Medical Specialists (UEMS) — Member · Dal 2020
Articoli di questo medico
- Patient education Patient guide to Ematologia
- Awareness When should you see a ematologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · dr.saad.rassam@euroclinics.example
Posizione
1 tagRecensioni dei pazienti
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.